文献速递神经肿瘤

H3K27M突变在「非中线」大脑半球高级别胶质瘤中的意义

Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres.
PubMed 文献 · World Neurosurg · 2019-08-12

本文报告一例48岁女性胼胝体压部伴双侧半球扩展的高级别胶质瘤,活检确诊为WHO IV级弥漫性星形细胞肿瘤,免疫组化显示H3K27M突变型核表达,患者活检后3个月死亡。作者据此提出H3K27M突变可能不仅是弥漫性中线胶质瘤、也可能是大脑半球胶质瘤的不良预后指标,并呼吁鼓励报告此类罕见病例。

要点

  • H3K27M突变型弥漫性中线胶质瘤自2016年WHO中枢神经系统分类起为独立病理实体。
  • 本例为非中线部位(胼胝体压部伴双侧半球扩展)WHO IV级胶质瘤伴H3K27M突变。
  • 作者提出H3K27M突变或可作为大脑半球胶质瘤的预后指标,但需更多报告验证。

核心结论

  • H3K27M突变可能对非中线大脑半球高级别胶质瘤同样具有不良预后影响。
  • H3K27M突变或可作为不仅限于弥漫性中线胶质瘤的可靠预后指标。
  • 因该突变在此类情形中罕见且认识有限,应鼓励报告相关病例。

研究设计与样本

  • 单个病例报告:48岁女性,胼胝体压部肿块伴双侧半球扩展,MRI呈高级别胶质瘤特征。
  • 行针刺活检,确诊为WHO IV级弥漫性星形细胞肿瘤。
  • 肿瘤免疫组化显示H3K27M突变型核表达。

主要发现

  • 患者活检后接受辅助治疗,于活检后3个月死亡。
  • 肿瘤起源于胼胝体压部并向双侧大脑半球扩展,属非中线非典型部位。
  • 免疫组化证实肿瘤存在H3K27M突变型核表达。

关键数值与推荐

  • 2016年WHO中枢神经系统分类将「弥漫性中线胶质瘤H3K27M突变型」列为独立病理实体,涵盖丘脑、脑干和脊髓等中线结构。
  • H3K27M突变型胶质瘤治疗反应较差、临床结局更差。
  • 突变检测目前对「弥漫性中线胶质瘤」具有诊断意义。

临床怎么用

  • 对大脑半球高级别胶质瘤亦应关注H3K27M突变状态,以辅助预后判断。
  • 非中线部位检出H3K27M突变时,应认识到其可能提示不良病程。
  • 此类罕见病例应积极报告,以积累预后与治疗证据。

局限性

  • 本文为单个病例报告,H3K27M突变在大脑半球胶质瘤中的意义仍需更多病例验证。
  • 作者指出该特定突变在此情形下罕见且认识有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: "Diffuse midline glioma H3K27M-mutant" (a mutation gene encoding H3 histone variants) represents a defined pathologic entity since the 2016 World Health Organization Central Nervous System classification and includes midline structures, namely the thalamus, brainstem, and spinal cord. H3K27M-mutant glioma responds more poorly and is associated with worse clinical outcome. Mutation detection is now diagnostic for "diffused midline gliomas." We report on a case arising in an atypical nonmidline localization with an exceedingly adverse course. The present case raises the question of the possible meaning of the H3K27M-mutation in high-grade gliomas arising from the cerebral hemispheres and its implications from prognostic and therapeutic views. CASE DESCRIPTION: A 48-year-old woman was admitted with a mass arising from the splenium of the corpus callosum with bilateral hemispheric extension, displaying magnetic resonance imaging characteristics typical of a high-grade glioma. Needle biopsy confirmed the diagnosis of "diffuse astrocytic neoplasm, World Health Organization grade IV." Immunostaining of the tumor revealed the H3K27M-mutant nuclear expression. The patient was referred to adjuvant therapy and died 3 months after biopsy. CONCLUSIONS: This experience highlights the possible negative prognostic impact of H3K27M-m and possibility that H3K27M-m could be a reliable prognostic indicator to be considered in not only diffuse midline gliomas but also gliomas from the cerebral hemispheres. Because of the rarity and limited knowledge of this specific mutation in this experience, reports should be encouraged.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. La Rocca G, Sabatino G, Altieri R, et al. Significance of H3K27M Mutation in "Nonmidline" High-Grade Gliomas of Cerebral Hemispheres. World Neurosurg. 2019. PMID: 31415896. doi:10.1016/j.wneu.2019.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。